We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $875B
1-Year Est. Return 40.91%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
-13.42%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$390B
AUM Growth
-$94.7B
Cap. Flow
+$10.4B
Cap. Flow %
2.66%
Top 10 Hldgs %
28.21%
Holding
14,957
New
1,520
Increased
5,503
Reduced
5,522
Closed
2,191

Sector Composition

Rank Sector Weight
1 Healthcare 2.83%
2 Technology 2.79%
3 Financials 2.29%
4 Consumer Discretionary 1.93%
5 Industrials 1.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LTCH
12151
PUT
DELISTED
Latch, Inc. Common Stock
LTCH
$29K ﹤0.01%
25,000
+11,500
+85% +$29.4K
WTT
12152
CALL
DELISTED
Wireless Telecom Group, Inc.
WTT
$29K ﹤0.01%
+21,900
New +$32.9K
ADIL
12153
CALL
Adial Pharmaceuticals
ADIL
$10.5M
$28K ﹤0.01%
+34
New +$30.8K
BBAI.WS icon
12154
BigBear.ai Holdings Warrant
BBAI.WS
$38.5M
$28K ﹤0.01%
70,247
-18,432
-21% -$14.6K
BTOG icon
12155
Bit Origin
BTOG
$3.41M
$28K ﹤0.01%
+36
New +$51.5K
BWEN icon
12156
PUT
Broadwind
BWEN
$127M
$28K ﹤0.01%
16,800
-25,800
-61% -$46.2K
CDTX
12157
DELISTED
Cidara Therapeutics
CDTX
$28K ﹤0.01%
+2,868
New +$35.4K
CLRB icon
12158
Cellectar Biosciences
CLRB
$24.6M
$28K ﹤0.01%
+230
New +$32.9K
DRTSW icon
12159
Alpha Tau Medical Warrant
DRTSW
$87.6M
$28K ﹤0.01%
54,582
+396
+0.7% +$221
IRON icon
12160
PUT
Disc Medicine
IRON
$3.03B
$28K ﹤0.01%
+553
New +$24.5K
MFG icon
12161
PUT
Mizuho Financial
MFG
$132B
$28K ﹤0.01%
12,300
-700
-5% -$1.65K
PLG
12162
Platinum Group Metals
PLG
$189M
$28K ﹤0.01%
20,979
-138,266
-87% -$238K
PPBT
12163
Purple Biotech
PPBT
$2.44M
$28K ﹤0.01%
+60
New +$35.9K
QSI icon
12164
PUT
Quantum-Si Incorporated
QSI
$162M
$28K ﹤0.01%
12,000
-1,400
-10% -$5.36K
SCNI
12165
Scinai Immunotherapeutics
SCNI
$1.25M
$28K ﹤0.01%
238
-184
-44% -$25.3K
UROY
12166
CALL
Uranium Royalty Corp
UROY
$1.57B
$28K ﹤0.01%
+12,200
New +$39.1K
VTVT icon
12167
vTv Therapeutics
VTVT
$119M
$28K ﹤0.01%
+932
New +$23.9K
VVOS icon
12168
CALL
Vivos Therapeutics
VVOS
$4.77M
$28K ﹤0.01%
856
+4
+0.5% +$166
PHLT
12169
PUT
DELISTED
Performant Healthcare Inc
PHLT
$28K ﹤0.01%
10,700
-200
-2% -$496
RNLX
12170
PUT
DELISTED
Renalytix plc American Depositary Shares
RNLX
$28K ﹤0.01%
11,600
ACER
12171
DELISTED
Acer Therapeutics Inc
ACER
$28K ﹤0.01%
+22,574
New +$47.3K
EXN
12172
DELISTED
Excellon Resources Inc.
EXN
$28K ﹤0.01%
+62,000
New +$39K
CIG icon
12173
PUT
CEMIG Preferred Shares
CIG
$5.52B
$27K ﹤0.01%
+17,316
New +$30.3K
CTMX icon
12174
CALL
CytomX Therapeutics
CTMX
$732M
$27K ﹤0.01%
14,700
-1,900
-11% -$3.64K
LAB icon
12175
PUT
Standard BioTools
LAB
$280M
$27K ﹤0.01%
17,100
-3,400
-17% -$8.41K

Similar funds

Ken Griffin's Q2 2022 Portfolio in Review

As of Q2 2022, Ken Griffin held 14,957 positions worth $390B, down 20% from $484B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Ken Griffin's Q2 2022 filing shows 1,520 new, 5,503 increased, 5,522 reduced and 2,191 closed positions. Its largest new stake was ResMed: 1,280,595 shares worth $268M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $576M.

By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.

  • Ken Griffin's largest Q2 2022 buy was ResMed: 1,280,595 shares worth $268M.
  • Ken Griffin added most to Meta Platforms (Facebook) in Q2 2022, an estimated $772M increase.
  • Ken Griffin's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $576M.
  • Ken Griffin fully exited Vanguard Morningstar Small-Cap ETF in Q2 2022, selling an estimated $184M.
  • Ken Griffin's ten largest holdings make up 28% of its $390B portfolio in Q2 2022.
  • Ken Griffin opened 1,520 new positions and closed 2,191 in Q2 2022.
  • Ken Griffin's portfolio value fell 20% quarter-over-quarter to $390B.

Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.